(Total Views: 309)
Posted On: 05/29/2019 11:18:05 AM
Post# of 7619
$DECN $JNJ
Panacea Product “GenUltimate TBG” Poised for June 6, 2019 Launch Decision Diagnostics Corp (DECN) vs Johnson & Johnson (JNJ) Litigation Update
LOS ANGELES, CA - May 29, 2019 - Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ('Sunshine') diabetes test strip, the internationally launched GenSure! Read More. See More Information: http://www.thestreetnow.com/spotlight/dailynews/ ..
Panacea Product “GenUltimate TBG” Poised for June 6, 2019 Launch Decision Diagnostics Corp (DECN) vs Johnson & Johnson (JNJ) Litigation Update
LOS ANGELES, CA - May 29, 2019 - Decision Diagnostics Corp. (OTC PINK: DECN) is a 17 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ('Sunshine') diabetes test strip, the internationally launched GenSure! Read More. See More Information: http://www.thestreetnow.com/spotlight/dailynews/ ..
(0)
(0)Scroll down for more posts ▼
